logo
Sign in

SIBN Stock Price, Chart, Stats & News

SI-BONE, Inc.
Save
707.37M
Market cap
Current P/E
Forward P/E

SIBN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
79.57%
Operating margin
-11.11%
Pretax margin
-9.41%
Net margin
-9.41%
Effective tax rate
ROA
-7.93%
ROE
-11.00%
D/E
0.01x
Interest coverage ratio
-8.50x

SIBN valuation

P/E
P/S
2.70x
P/B
3.01x
P/CF
-792.16x
P/FCF
-59.72x
P/OCF
-792.16x
PEG
-2.06x
EV multiple
-68.97x

About

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring.

Similar securities

Based on sector and market capitalization

Report issue